Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. MediPharm Labs Corp.
  6. News
  7. Summary
    LABS   CA58504D1006

MEDIPHARM LABS CORP.

(LABS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

MediPharm Labs : Narrows Q1 Loss as Revenue Shrinks

05/17/2021 | 08:48am EDT


ę MT Newswires 2021
All news about MEDIPHARM LABS CORP.
06/10MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Share..
GL
06/08MediPharm Labs Extends Germany Supply Deal with Cannabis Distributor ADREXpha..
MT
06/08MEDIPHARM LABSá : Extends Strategic Partnership with ADREXpharma and continues t..
AQ
06/02MEDIPHARM LABSá : Acquisition of Securities of MediPharm Labs Corp
AQ
05/27MEDIPHARM LABSá : Launches High-CBD Wellness Oils in Quebec; Ships First Order o..
AQ
05/27REPEAT -- MediPharm Labs Launches High-CBD Wellness Oils in Quebec; Ships Fir..
GL
05/26MediPharm Labs Jumped 9.1% Today; Then Launches High-CBD Wellness Oils in Que..
MT
05/26MediPharm Labs Launches High-CBD Wellness Oils in Quebec; Ships First Order o..
GL
05/17MEDIPHARM LABSá : Narrows Q1 Loss as Revenue Shrinks
MT
05/17MEDIPHARM LABS BRIEF : Net Loss For 3 Months Ended March 31. 2021, Was 13.867 Ml..
MT
More news
Financials
Sales 2021 36,0 M 29,6 M 29,6 M
Net income 2021 -30,6 M -25,2 M -25,2 M
Net cash 2021 59,0 M 48,5 M 48,5 M
P/E ratio 2021 -3,86x
Yield 2021 -
Capitalization 140 M 115 M 115 M
EV / Sales 2021 2,26x
EV / Sales 2022 0,48x
Nbr of Employees 204
Free-Float 92,5%
Chart MEDIPHARM LABS CORP.
Duration : Period :
MediPharm Labs Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIPHARM LABS CORP.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 0,69 CAD
Last Close Price 0,54 CAD
Spread / Highest target 85,2%
Spread / Average Target 28,1%
Spread / Lowest Target -25,9%
EPS Revisions
Managers and Directors
NameTitle
Keith Strachan Chief Executive Officer, President & Director
Greg Hunter Chief Financial Officer
Patrick McCutcheon Chairman
Ina Shira Dubinsky Lead Scientist-Secondary Processing
William Gordon Director-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
MEDIPHARM LABS CORP.1.89%115
CURALEAF HOLDINGS, INC.16.01%10 222
CANOPY GROWTH CORPORATION0.38%9 902
BEIJING TONGRENTANG CO., LTD45.56%7 457
DONG-E-E-JIAO CO.,LTD.-7.78%3 593
CRONOS GROUP INC.22.40%3 307